Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
The technique could help patients with currently untreatable diseases such as Huntington’s.
A biotech company founded by Craig Mello, codiscoverer of RNAi, brings its first self-delivering interfering RNA to clinical trial.
A new study reveals the influence of large RNA molecules in controlling stem cells.
Repetitive stretches of RNA are found in high concentrations in cancer cells.
Using RNA instead of DNA could avoid the health risks–and the political pitfalls–of stem-cell treatments.
A new type of genetic switch gives bioengineers better control over microbes.
Drugmakers place big bets on the emerging science of microRNA.
In first human trial, particles successfully reach cancer cells and silence the target gene.
A new drug suppresses the virus in chimps without generating resistance.